Randomized Therapy In Status Epilepticus

Clinical trial NCT04391569 · COMPLETED

Trial details

NCT number: NCT04391569
Sponsor: Marinus Pharmaceuticals
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Status Epilepticus

Start date: 2020-12-09
Primary completion: 2024-03-30
Enrollment: 100

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.